Overexpression of SIRT1 and SIRT2 promoted the survival of chronic lymphocytic leukemia (CLL) B cells and correlated with poor outcome in patients with CLL (80, 81). The gene discussed is SIRT1; the disease is B-cell chronic lymphocytic leukemia.